PuSH - Publication Server of Helmholtz Zentrum München

Scala, E.* ; Cacciapuoti, S.* ; Garzorz-Stark, N.* ; Megna, M.* ; Marasca, C.* ; Seiringer, P. ; Volz, T.* ; Eyerich, K.* ; Fabbrocini, G.*

Hidradenitis suppurativa: Where we are and where we are going.

Cells 10:2094 (2021)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease primarily affecting apocrine gland-rich areas of the body. It is a multifactorial disease in which genetic and environmental factors play a key role. The primary defect in HS pathophysiology involves follicular occlusion of the folliculopilosebaceous unit, followed by follicular rupture and immune responses. Innate pro-inflammatory cytokines (e.g., IL-1β, and TNF-α); mediators of activated T helper (Th)1 and Th17 cells (e.g., IFN-γ, and IL-17); and effector mechanisms of neutrophilic granulocytes, macrophages, and plasma cells are involved. On the other hand, HS lesions contain anti-inflammatory mediators (e.g., IL-10) and show limited activity of Th22 cells. The inflammatory vicious circle finally results in pain, purulence, tissue destruction, and scarring. HS pathogenesis is still enigmatic, and a valid animal model for HS is currently not available. All these aspects represent a challenge for the development of therapeutic approaches, which are urgently needed for this debilitating disease. Available treatments are limited, mostly off-label, and surgical interventions are often required to achieve remission. In this paper, we provide an overview of the current knowledge surrounding HS, including the diagnosis, pathogenesis, treatments, and existing translational studies.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Review
Corresponding Author
Keywords Diagnosis ; Hidradenitis Suppurativa ; Pathogenesis ; Translational Studies ; Treatments; Nonsteroidal Antiinflammatory Drugs; Keratinocyte Function; Interferon-gamma; Disease Severity; Scoring System; Pathogenesis; Diagnosis; Mechanisms; Adalimumab; Expression
ISSN (print) / ISBN 2073-4409
e-ISSN 2073-4409
Journal Cells
Quellenangaben Volume: 10, Issue: 8, Pages: , Article Number: 2094 Supplement: ,
Publisher MDPI
Publishing Place Basel
Non-patent literature Publications